insights_auto
Why is TNXP down 4.32%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
US$2.88
arrow_downward
-4.32%(-0.13) 1D
US$2.93
arrow_upward
+1.74% (+0.050)bedtimeAfter hours
Closed: ኖቬም 16, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
US$3.02
High
US$3.08
Low
US$2.81
Mkt. cap
55.96 ሚ
Avg. vol.
1.16 ሚ
Volume
1.22 ሚ
52-wk high
US$20.56
52-wk low
US$2.81
EPS
-US$12.92
Beta
1.90
Shares outstanding
19.43 ሚ
No. of employees
142
Open
US$3.02
High
US$3.08
Low
US$2.81
Mkt. cap
55.96 ሚ
Avg. vol.
1.16 ሚ
Volume
1.22 ሚ
52-wk high
US$20.56
52-wk low
US$2.81
EPS
-US$12.92
Beta
1.90
Shares outstanding
19.43 ሚ
No. of employees
142
News stories
From web sources and news partners
Zacks Small Cap Research
·
ከ12 ሰዓቶች በፊት
TNXP: Tonmya® Launch Continues to Build Momentum; 37% QoQ Growth in Revenue
Yahoo Finance
·
ከ3 ቀናት በፊት
TNXP 8-K & SEC Filings
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websitetonixpharma.com